Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

remedyrepack inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.1 mg - caziant (desogestrel and ethinyl estradiol tablets) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table 2 lists the typical unintended pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and implants, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year * method typical use † perfect use ‡ (1) (2) (3) (4) chance § 85 85 spermicides ¶ 26 6 40 periodic abstinence 25 63 calendar 9 ovulation method 3 sympto-thermal # 2 post-ovulation 1 withdrawal 19 4 cap Þ parous women 40 26 42 nulliparous women 20 9 56 sponge parous women 40 20 42 nulliparous women 20 9 56 diaphragm Þ 20 6 56 condom

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

mayne pharma inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.1 mg - caziant (desogestrel and ethinyl estradiol tablets) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table 2 lists the typical unintended pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and implants, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year * method typical use † perfect use ‡ (1) (2) (3) (4) chance§ 85 85 spermicides¶ 26 6 40 periodic abstinence 25 63 calendar 9 ovulation method 3 sympto-thermal# 2 post-ovulation 1 withdrawal 19 4 capÞ parous women 40 26 42 nulliparous women 20 9 56 sponge parous women 40 20 42 nulliparous women 20 9 56 diaphragmÞ 20 6 56 condomß  female

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - caziant (desogestrel and ethinyl estradiol tablets) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table 2 lists the typical unintended pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and implants, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year * method typical use † perfect use ‡ (1) (2) (3) (4) chance§ 85 85 spermicides¶ 26 6 40 periodic abstinence 25 63 calendar 9 ovulation method 3 sympto-thermal# 2 post-ovulation 1 withdrawal 19 4 capÞ parous women 40 26 42 nulliparous women 20 9 56 sponge parous women 40 20 42 nulliparous women 20 9 56 diaphragmÞ 20 6 56 condomß  female

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

abs global inc. - lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at), dodecylbenzenesulfonic acid (unii: 60nsk897g9) (dodecylbenzenesulfonic acid - unii:60nsk897g9) - lactic acid 23 mg in 1 ml - directions for use mix directions: add 3.5 ounces of valiant catalyst (us) to one gallon of valiant foam active or mix (27.3 ml valiant catalyst (us) to 1 liter valiant foam active). inverting the container approximately 5-7 times will adequately mix the two solutions. pour the mixed solution into the valiant foam active wipe bucket or foaming teat dip cup. this mixed solution will remain stable for 7 days. after 7 days, discard solution and mix a new solution. important: do not add mixed valiant foam active to any other teat dip or other products. directions for pre-milking application: wipe: apply to teats using wipes from the valiant foam active wipe kit. use one wipe per cow. foaming cup: apply foam to teats before milking, leaving sufficient contact time before wiping off with a single service towel. if product in dip cup becomes visibly dirty, discard contents and replenish. do not reuse or return unused product to the original container. note: valiant foam active is not intended to cure or help in

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

abs global inc. - lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at), dodecylbenzenesulfonic acid (unii: 60nsk897g9) (dodecylbenzenesulfonic acid - unii:60nsk897g9) - lactic acid 23.37 mg in 1 ml - directions for use mix directions: add 3.5 ounces of valiant catalyst (us) to one gallon of valiant pre (us) or mix (27.3 ml valiant catalyst (us) to 1 liter valiant pre (us)) and mix. inverting the container approximately 5-7 times will adequately mix the two solutions. this mixed solution will remain stable for 7 days. after 7 days, discard solution and mix a new solution. important: do not add mixed valiant pre (us) ready-to-use to any other teat dip or other products. if transferred from this container to any other, make sure the other container is thoroughly pre-cleaned and bears the proper container labeling for valiant pre (us). use of a complete cow-care program including both pre and post dipping may aid in reducing the spread of organisms which may cause mastitis. directions for pre-milking fill teat dip cup with valiant pre (us). before each cow is milked, dip the teats as far as possible into the teat dip cup containing valiant pre (us). wipe teats dry after dipping, using single-service towels

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

abs global inc. - lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at), dodecylbenzenesulfonic acid (unii: 60nsk897g9) (dodecylbenzenesulfonic acid - unii:60nsk897g9) - lactic acid 23.51 mg in 1 ml - directions for use mix directions : add 3.5 ounces of valiant catalyst (us) to one gallon of valiant pre/post (us) or mix (27.3 ml valiant catalyst (us) to 1 liter valiant pre/post (us)) and mix. inverting the container approximately 5-7 times will adequately mix the two solutions. this mixed solution will remain stable for 7 days. after 7 days, discard solution and mix a new solution. important : do not add mixed valiant pre/post (us) ready-to-use to any other teat dip or other products. if transferred from this container to any other, make sure the other container is thoroughly pre-cleaned and bears the proper container labeling for valiant pre/post (us). use of a complete cow-care program including both pre and post dipping may aid in reducing the spread of organisms which may cause mastitis. directions for teat dipping pre-milking : fill teat dip cup with valiant pre/post (us). before each cow is milked, dip the teats as far as possible into the teat dip cup containing valiant pre/post (us). wipe teats dr

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

abs global inc. - lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at), heptanoic acid (unii: the3ynp39d) (heptanoic acid - unii:the3ynp39d) - lactic acid 14.27 mg in 1 ml - directions for use mix directions: add 3.5 ounces of valiant catalyst (us) to one gallon of valiant shield and mix. inverting the container approximately 5-7 times will adequately mix the two solutions. this mixed solution will remain stable for 7 days. after 7 days, discard solution and mix a new solution. important: do not add mixed valiant shield ready-to-use to any other teat dip or other products. if transferred from this container to any other, make sure the other container is thoroughly pre-cleaned and bears the proper container labeling for valiant shield. use of a complete cow-care program including both pre and post dipping may aid in reducing the spread of organisms which may cause mastitis. directions for teat dipping post-milking: immediately after milking, use the mixed valiant shield solution at full strength. submerge the teat 2/3 of its length in the solution. allow to air dry. do not wipe. always use mixed, uncontaminated, full strength solution. if product in dip cup becomes visibly dirt

Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ranvet pty. limited - detomidine hydrochloride - parenteral liquid/solution/suspension - detomidine hydrochloride imidazole active 10.0 mg/ml - anaesthetics/analgesics - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - analgesic | sedative | antipyretic | colic | muscle relaxant | sedative | spasmolytic

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 35281 - graft, vascular, synthetic - the valiant thoracic stent graft with the captivia delivery system consists of the following components - the valiant thoracic stent graft and the captivia delivery system. the valiant thoracic stent graft is pre-loaded into the captivia delivery system. the loaded delivery system accommodates a 0.89 mm guidewire and is inserted endoluminally via the femoral or iliac artery and tracked through the patient's vasculature to deliver the stent to the target site. the valiant thoracic stent graft with the captivia delivery system is indicated for the treatment of diseases of the descending thoracic aorta including but not limited to aneurysms and dissections. the valiant thoracic stent graft is indicated for exclusion of the aneurysm, the false lumen or site of rupture and restoration of blood flow through the stent graft lumen. the device is intended for use in patients who are candidates for conventional surgical repair and in patients who are not candidates for conventional surgical repair due to pre-existing r

New Zealand - Inggeris - Ministry for Primary Industries

ravensdown limited - haloxyfop-p - haloxyfop-p 520 g/litre - herbicide